Patents by Inventor Flavio VINCENTI

Flavio VINCENTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND ANTIBODIES IN TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
    Publication number: 20230348613
    Abstract: The present disclosure provides methods of use of antibodies that specifically bind to urokinase plasminogen activator receptor (uPAR/CD87), as well as to is its soluble counterpart, soluble uPAR (suPAR), in treatment or prevention of focal segmental glomerulosclerosis (FSGS).
    Type: Application
    Filed: June 3, 2021
    Publication date: November 2, 2023
    Inventors: Charles S. Craik, Flavio Vincenti
  • BEAD-FREE EX-VIVO EXPANSION OF HUMAN REGULATORY T CELLS
    Publication number: 20220204931
    Abstract: The present disclosure relates generally to the manufacture of regulatory T cells (Tregs) for use in adoptive cell therapy. In particular, the present disclosure relates to simplified approaches for the expansion of Tregs ex vivo. Tregs produced in this way are suitable for use in various immunotherapy regimens.
    Type: Application
    Filed: April 30, 2020
    Publication date: June 30, 2022
    Applicant: The Regents of the University of California
    Inventors: Qizhi TANG, Nikolaos SKARTSIS, Flavio VINCENTI